Metabolic Effects of an 8 Week Niaspan Treatment in Patients With

Status Completed

Clinical Trial Summary

Nicotinic acid (Niacin) has been used for many years for the treatment of dyslipidemia. Indeed Niacin decreases triglycerides (TG) and low density lipoprotein cholesterol (LDL-c) but more importantly increases high density lipoprotein cholesterol (HDL-c). Although the drug has been used for so long, its precise mechanism of action remains elusive. The aim of this study was to characterise the metabolic changes induced by 8 week treatment with Niacin in dyslipidemic, overweight patients. The importance of the inhibition of lipolysis on the overall lipid effects of niacin will be studied. In order to get a very comprehensive view of all metabolic activities of niacin, this study will investigate the potential effects of niacin on Glucose metabolism, lipid and lipoprotein turnover, quantitative changes in lipoproteins and key enzymes involved in lipid metabolism.

Clinical Trial Description

24 patients will be included in a double blind placebo controlled cross-over 8 week study comparing placebo to Niaspan (a long release formulation of niacin). In order to prevent any drop out linked to the flushing side effect of niacin, patient will take aspirin (300mg) prior to treatment throughout the study duration. The study will include at start and end of each arm, a full lipoproteins quantification as well as a measure of enzymes involved in lipid metabolism. On day 42 and 56 of each period, after an administration of either placebo or 500mg of immediate release niacin respectively, changes in plasma free fatty acid levels will be measured for 8hours in order to assess potential loss of activity of niacin over time upon chronic treatment with niaspan. Half of the patient will have an exploration of their glucose metabolism using hyperinsulinic clamp technique, whereas in the other half a metabolic turnover study using stable isotopes will focus on their lipoproteins, triglycerides and cholesterol handling. These explorations will be done at the end of each treatment period. ;

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01216956
Study type	Interventional
Source	Centre de Recherche en Nutrition Humaine Rhone-Alpe
Contact
Status	Completed
Phase	N/A
Start date	September 2006
Completion date	March 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03458741` - How is Glycogen Supercompensation Regulated in Human Skeletal Muscle	N/A
Recruiting	`NCT06042517` - Mechanisms of Ultrasound Neuromodulation Effects in Diabetes	N/A
Completed	`NCT03859934` - Metabolic Effects of Melatonin Treatment	Phase 1
Completed	`NCT03689738` - Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety	N/A
Recruiting	`NCT04195165` - The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test	N/A
Recruiting	`NCT05441982` - Saccharin and Acesulfame Potassium Consumption and Glucose Homeostasis in Older Adults With Prediabetes	N/A
Terminated	`NCT03325933` - Resistance Training and Cardiometabolic Health	N/A
Recruiting	`NCT05791968` - Blood Donation Could Improve Insulin Sensitivity	N/A
Completed	`NCT02700698` - Mitochondrial Function in Circulating Cells and Muscle Tissue
Completed	`NCT02913079` - The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels	N/A
Suspended	`NCT03240978` - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese	N/A
Recruiting	`NCT01972113` - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)	N/A
Completed	`NCT02058914` - Effects of Sugar Sweetened Beverage on Metabolic Health in Male and Female Adolescents	N/A
Enrolling by invitation	`NCT02192684` - Obesity, Sleep Apnea, and Insulin Resistance	N/A
Completed	`NCT00936130` - Bariatric Surgery and Weight Loss on Energy Metabolism and Insulin Sensitivity	N/A
Recruiting	`NCT05992688` - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)	N/A
Recruiting	`NCT04168372` - Fructose: Substrate, Stimulus, or Both?	N/A
Recruiting	`NCT05443347` - Activity, Adiposity, and Appetite in Adolescents 2 Intervention	N/A
Terminated	`NCT04239482` - Nutritional Supplementation and Insulin Sensitivity	N/A
Withdrawn	`NCT03452267` - Insulin Signaling in Skeletal Muscle	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms